Madhavan Balachandran
Director/Board Member bei UNIQURE N.V.
Vermögen: 3 Mio $ am 31.03.2024
Profil
Zurzeit ist Madhavan Balachandran Chief Operating Officer bei Brentwood Press & Publishing Co. und Chief Operating Officer bei Nutcracker Therapeutics, Inc. Herr Balachandran ist außerdem im Vorstand von 5 weiteren Unternehmen. In der Vergangenheit hatte Herr Balachandran die Position des Chief Executive Officer & Director bei ADRx, Inc. inne, die des Executive Vice President bei Amgen, Inc. die des Vice President-Engineering bei Glaxo Wellcome, Inc. die des Principal beim Battelle Memorial Institute und die des Vice President der Puerto Rico USA Citizenship Foundation. Er erwarb einen MBA an der East Carolina University, einen Undergraduate-Abschluss am Indian Institute of Technology Bombay und einen Graduate-Abschluss an der State University of New York in Buffalo.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
07.03.2024 | 58 103 ( 0,02% ) | 2 Mio $ | 31.03.2024 | |
CATALENT INC
0,01% | 04.12.2023 | 20 448 ( 0,01% ) | 1 Mio $ | 31.03.2024 |
UNIQURE N.V.
0,04% | 15.09.2023 | 17 290 ( 0,04% ) | 89 908 $ | 31.03.2024 |
Aktive Positionen von Madhavan Balachandran
Unternehmen | Position | Beginn |
---|---|---|
UNIQURE N.V. | Director/Board Member | 14.09.2017 |
STEVANATO GROUP S.P.A. | Director/Board Member | 01.09.2018 |
Fortuna Fix, Inc.
Fortuna Fix, Inc. BiotechnologyHealth Technology Fortuna Fix, Inc. operates as a clinical-stage regenerative medicine firm. It develops a patented direct cell reprogramming technology platform (drNPC) and a proprietary bio-scaffolding technology (RMx), for the treatment of neurodegenerative diseases and neurotrauma. The company is headquartered in Laval, Canada. | Director/Board Member | 01.06.2018 |
Nutcracker Therapeutics, Inc.
Nutcracker Therapeutics, Inc. Information Technology ServicesTechnology Services Nutcracker Therapeutics, Inc. provides Biotechnology services. It offers push button operation, rapid cycle times and delivery vehicles. The company was founded by Igor Khandros and Benjamin Eldridge in 2018 and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 23.09.2020 |
Brentwood Press & Publishing Co.
Brentwood Press & Publishing Co. Publishing: NewspapersConsumer Services Brentwood Press & Publishing Co. publishes newspapers. It offers print and digital media, website design, social media training and consultation. The company was founded by James Chamoures and is headquartered in Brentwood, CA. | Chief Operating Officer | 23.09.2020 |
A2 Biotherapeutics, Inc.
A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services A2 Biotherapeutics, Inc. operates as a biotechnology company. It develops medicines. The company was founded by Alexander Kamb, Michael Gallo and Paul Kang in 2018 and is headquartered in Westlake Village, CA. | Director/Board Member | - |
Ehemalige bekannte Positionen von Madhavan Balachandran
Unternehmen | Position | Ende |
---|---|---|
CATALENT, INC. | Director/Board Member | 25.01.2024 |
ADRx, Inc.
ADRx, Inc. Pharmaceuticals: MajorHealth Technology ADRx, Inc. is a biopharmaceutical company. The firm advances drug candidates for Alzhiemer’s disease, systemic amyloidosis and ovarian cancer. The company was founded by Gary Wilcox and David Eisenberg and is headquartered in Thousand Oaks, CA. | Chief Executive Officer | 01.10.2020 |
AMGEN INC. | Chief Operating Officer | 01.01.2001 |
░░░░░░ ░░░░ ░░░ ░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Madhavan Balachandran
East Carolina University | Masters Business Admin |
State University of New York at Buffalo | Graduate Degree |
Indian Institute of Technology Bombay | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
AMGEN INC. | Health Technology |
STEVANATO GROUP S.P.A. | Health Technology |
UNIQURE N.V. | Health Technology |
CATALENT, INC. | Health Technology |
Private Unternehmen | 8 |
---|---|
Battelle Memorial Institute
Battelle Memorial Institute Miscellaneous Commercial ServicesCommercial Services Battelle Memorial Institute operates as a science and technology development company. It offers services for government and commercial. The company was founded by Gordon Battelle in 1929 and is headquartered in Columbus, OH. | Commercial Services |
Brentwood Press & Publishing Co.
Brentwood Press & Publishing Co. Publishing: NewspapersConsumer Services Brentwood Press & Publishing Co. publishes newspapers. It offers print and digital media, website design, social media training and consultation. The company was founded by James Chamoures and is headquartered in Brentwood, CA. | Consumer Services |
Glaxo Wellcome, Inc. | Health Technology |
Puerto Rico USA Citizenship Foundation | |
Fortuna Fix, Inc.
Fortuna Fix, Inc. BiotechnologyHealth Technology Fortuna Fix, Inc. operates as a clinical-stage regenerative medicine firm. It develops a patented direct cell reprogramming technology platform (drNPC) and a proprietary bio-scaffolding technology (RMx), for the treatment of neurodegenerative diseases and neurotrauma. The company is headquartered in Laval, Canada. | Health Technology |
A2 Biotherapeutics, Inc.
A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services A2 Biotherapeutics, Inc. operates as a biotechnology company. It develops medicines. The company was founded by Alexander Kamb, Michael Gallo and Paul Kang in 2018 and is headquartered in Westlake Village, CA. | Commercial Services |
Nutcracker Therapeutics, Inc.
Nutcracker Therapeutics, Inc. Information Technology ServicesTechnology Services Nutcracker Therapeutics, Inc. provides Biotechnology services. It offers push button operation, rapid cycle times and delivery vehicles. The company was founded by Igor Khandros and Benjamin Eldridge in 2018 and is headquartered in Emeryville, CA. | Technology Services |
ADRx, Inc.
ADRx, Inc. Pharmaceuticals: MajorHealth Technology ADRx, Inc. is a biopharmaceutical company. The firm advances drug candidates for Alzhiemer’s disease, systemic amyloidosis and ovarian cancer. The company was founded by Gary Wilcox and David Eisenberg and is headquartered in Thousand Oaks, CA. | Health Technology |